국내 희귀의약품의 현황 및 과제  :  희귀질환에 대한 의약품 공급을 중심으로

= Current Status and Expectations of Orphan Drugs in Korea : In point of supplying medicines for the rare diseases

• 초록 (Abstract)
  • This study was aimed to investigate the curretit status and expectations of orphan drugs in Korea. The Korea Orphan Drug Center was established to supply many medicines for the patients with rare diseases. Among the medicines supplied by the Center, t...
• This study was aimed to investigate the curretit status and expectations of orphan drugs in Korea. The Korea Orphan Drug Center was established to supply many medicines for the patients with rare diseases. Among the medicines supplied by the Center, the number designated as the orphan drugs by the K-FDA is quite few. However, a few of medicines are not under circulation even if the items are designated as the orphan drugs. Neoplasm-related medicines, infectious and parasitic disease-related medicines, endocrine, nutritional and metabolic disease-related medicines are the ones circulated most. There are several unapproved drugs among the medicines supplied by the Center. It's because the director of the Center can import the goods without a process to getting an approval from the KFDA. The Korea Orphan Drug Center has contributed to the selection of the medicines for treating the rare disease. On the contrary, some problems remain in the supply process. The safety and effectiveness of the medicines supplied by the Center are not guaranteed. So far, rare diseases have no apecific legal definition, and therefore are only referred to in terms of the population of patients, which prevent from establishing the lange of medicines.
  The introduction of Special Access Program ot Access to Unapproved Therapeutic Goods will be the solution ot these problems, In addition, it is, another solution to keep intimate relations with the Rare and Intractable Disease Center and the Medicine Safety Infonnation Center which will be open soon.